{
    "nct_id": "NCT04130061",
    "official_title": "Safety and Feasibility Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation After Coronary Artery Bypass Grafting",
    "inclusion_criteria": "* Patients undergoing primary elective CABG at the University of Utah Hospital\n* Ability to provided informed consent and follow-up with protocol procedures\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients in AF at the time of surgery\n* Prior history of sternotomy\n* Prior history of pericarditis\n* Currently on aggressive antiarrhythmic therapy (does not include beta blockers)\n* Patients with an implantable cardiac device (pacemaker, ICD, CRT-D)\n* Ejection fraction <45%",
    "miscellaneous_criteria": ""
}